Skip to content

OPART/Prodiga, OPART/Protenza, OPART/Paragon

by Toshiba America Mri, Inc.

510(k) K993574

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK993574 Date18 Jan 2000ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LNH
Device Class
Class II
Regulation
21 CFR Part 892.1000
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The OPART/Prodiga, OPART/Protenza, and OPART/Paragon are Class II magnetic resonance imaging (MRI) systems designed for radiology applications. These devices utilize nuclear magnetic resonance technology to generate detailed images of internal body structures, aiding in the diagnosis and evaluation of various medical conditions.

These MRI systems are intended for use in clinical settings and are supplied as reusable medical equipment. They are classified under product code LNH and comply with FDA 510(k) clearance (K993574) for traditional review. The devices are manufactured by Toshiba America MRI, Inc., and are regulated under the U.S. Food and Drug Administration’s special controls for MRI systems.

Other devices from Toshiba America Mri, Inc.

See all devices from Toshiba America Mri, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these MRI systems designed for single-use or can they be reused in a clinical setting?

    The OPART/Prodiga, OPART/Protenza, and OPART/Paragon MRI systems are explicitly described as reusable medical equipment for clinical use. Since they are Class II devices intended for repeated imaging procedures, they must follow manufacturer guidelines for maintenance, cleaning, and sterilization to ensure safe and accurate operation.

  • What regulatory pathway was followed for FDA clearance of these MRI systems?

    These devices were cleared through the FDA 510(k) process under traditional review, with a clearance number of K993574. They fall under product code LNH and comply with the agency’s special controls for MRI systems, as indicated in the submission details.

  • Are there different models or configurations available for these MRI systems?

    The data provided lists multiple FEI numbers (e.g., 3008156140, 3021593788) associated with the OPART/Prodiga, OPART/Protenza, and OPART/Paragon systems, suggesting variations in specific configurations or software versions may exist. However, the core technology remains nuclear magnetic resonance imaging for radiology applications, and no distinct clinical indications are specified beyond general diagnostic imaging.

  • How should these MRI systems be stored to maintain their performance and safety?

    While the data does not specify storage conditions in detail, as reusable medical devices, these MRI systems should be stored in a controlled environment—protected from extreme temperatures, humidity, and physical damage—to preserve their structural integrity and calibration. Manufacturer instructions (not provided here) would outline proper storage protocols, including any required maintenance or environmental controls.